Profile: Rockland Immunochemicals, Inc. is a global biotechnology company manufacturing leading edge research tools and cGMP grade proteins for basic, applied & clinical research in functional genomics, gene therapy & drug discovery markets. We have the ability to custom produce antibodies as well as purify and conjugate them to exact specifications. Our antibodies are suited for individuals performing high throughput screening, drug discovery, diagnostic kit production and life science research. Some of our primary antibodies include apolipoproteins, apoptosis/cell cycle, cytokines, cell signaling, enzymes, extracellular matrix, transcription factors (NFkB) and ubiquitin. The secondary antibodies are conjugated to a broad range of enzymes, fluorophors and magnetic particles.

The company has revenues of USD 5-10 Million, has ~40 employees.